206 related articles for article (PubMed ID: 35565438)
1. Dissecting the Functional Role of the TRIM8 Protein on Cancer Pathogenesis.
Esposito JE; De Iuliis V; Avolio F; Liberatoscioli E; Pulcini R; Di Francesco S; Pennelli A; Martinotti S; Toniato E
Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565438
[TBL] [Abstract][Full Text] [Related]
2. Emerging Roles of TRIM8 in Health and Disease.
Marzano F; Guerrini L; Pesole G; Sbisà E; Tullo A
Cells; 2021 Mar; 10(3):. PubMed ID: 33807506
[TBL] [Abstract][Full Text] [Related]
3. Rise of TRIM8: A Molecule of Duality.
Bhaduri U; Merla G
Mol Ther Nucleic Acids; 2020 Dec; 22():434-444. PubMed ID: 33230447
[TBL] [Abstract][Full Text] [Related]
4. TRIM8: a double-edged sword in glioblastoma with the power to heal or hurt.
Hosseinalizadeh H; Mohamadzadeh O; Kahrizi MS; Razaghi Bahabadi Z; Klionsky DJ; Mirzei H
Cell Mol Biol Lett; 2023 Jan; 28(1):6. PubMed ID: 36690946
[TBL] [Abstract][Full Text] [Related]
5. Nucleo-cytoplasmic trafficking of TRIM8, a novel oncogene, is involved in positive regulation of TNF induced NF-κB pathway.
Tomar D; Sripada L; Prajapati P; Singh R; Singh AK; Singh R
PLoS One; 2012; 7(11):e48662. PubMed ID: 23152791
[TBL] [Abstract][Full Text] [Related]
6. TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role.
Caratozzolo MF; Marzano F; Mastropasqua F; Sbisà E; Tullo A
Genes (Basel); 2017 Nov; 8(12):. PubMed ID: 29182544
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TRIM8 restrains ischaemia-reperfusion-mediated cerebral injury by regulation of NF-κB activation associated inflammation and apoptosis.
Bai X; Zhang YL; Liu LN
Exp Cell Res; 2020 Mar; 388(2):111818. PubMed ID: 31917201
[TBL] [Abstract][Full Text] [Related]
8. TRIM8-driven transcriptomic profile of neural stem cells identified glioma-related nodal genes and pathways.
Venuto S; Castellana S; Monti M; Appolloni I; Fusilli C; Fusco C; Pucci P; Malatesta P; Mazza T; Merla G; Micale L
Biochim Biophys Acta Gen Subj; 2019 Feb; 1863(2):491-501. PubMed ID: 30528352
[TBL] [Abstract][Full Text] [Related]
9. TRIM8 modulates p53 activity to dictate cell cycle arrest.
Caratozzolo MF; Micale L; Turturo MG; Cornacchia S; Fusco C; Marzano F; Augello B; D'Erchia AM; Guerrini L; Pesole G; Sbisà E; Merla G; Tullo A
Cell Cycle; 2012 Feb; 11(3):511-23. PubMed ID: 22262183
[TBL] [Abstract][Full Text] [Related]
10. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
[TBL] [Abstract][Full Text] [Related]
11. Blocking of tripartite motif 8 protects against lipopolysaccharide (LPS)-induced acute lung injury by regulating AMPKα activity.
Xiaoli L; Wujun Z; Jing L
Biochem Biophys Res Commun; 2019 Jan; 508(3):701-708. PubMed ID: 30527811
[TBL] [Abstract][Full Text] [Related]
12. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
[TBL] [Abstract][Full Text] [Related]
13. Tripartite motif 8 (TRIM8) modulates TNFα- and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination.
Li Q; Yan J; Mao AP; Li C; Ran Y; Shu HB; Wang YY
Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19341-6. PubMed ID: 22084099
[TBL] [Abstract][Full Text] [Related]
14. TRIM8 inhibits breast cancer proliferation by regulating estrogen signaling.
Tian Z; Tang J; Liao X; Gong Y; Yang Q; Wu Y; Wu G
Am J Cancer Res; 2020; 10(10):3440-3457. PubMed ID: 33163282
[TBL] [Abstract][Full Text] [Related]
15. TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma.
Caratozzolo MF; Valletti A; Gigante M; Aiello I; Mastropasqua F; Marzano F; Ditonno P; Carrieri G; Simonnet H; D'Erchia AM; Ranieri E; Pesole G; Sbisà E; Tullo A
Oncotarget; 2014 Sep; 5(17):7446-57. PubMed ID: 25277184
[TBL] [Abstract][Full Text] [Related]
16. Suppression of TRIM8 by microRNA-182-5p restricts tumor necrosis factor-α-induced proliferation and migration of airway smooth muscle cells through inactivation of NF-Κb.
Dang X; He B; Ning Q; Liu Y; Chang Y; Chen M
Int Immunopharmacol; 2020 Jun; 83():106475. PubMed ID: 32283508
[TBL] [Abstract][Full Text] [Related]
17. Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways.
Tao Q; Tianyu W; Jiangqiao Z; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z
Int J Biol Sci; 2019; 15(8):1618-1629. PubMed ID: 31360105
[TBL] [Abstract][Full Text] [Related]
18. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
[TBL] [Abstract][Full Text] [Related]
19. Chalepin: A Compound from
Richardson JSM; Aminudin N; Abd Malek SN
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S489-S498. PubMed ID: 29142404
[TBL] [Abstract][Full Text] [Related]
20. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways.
Chen L; Huang J; Ji YX; Mei F; Wang PX; Deng KQ; Jiang X; Ma G; Li H
Hypertension; 2017 Feb; 69(2):249-258. PubMed ID: 27956576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
